The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 9th 2025
Though cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible safety risks.
Home-based Medication Errors Rose Between 2000 and 2012
July 12th 2017Home-based medication errors are becoming more common, according to a report from The Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital and published a study in Clinical Toxicology
Read More
CDC Releases Update on Influenza Virus During 2016-2017 Season
July 10th 2017The CDC has released trends on influenza activity in the United States during the 2016-2017 flu season. This data is updated yearly to consider new strains of the virus circulating in society and the overall length of the season.
Read More
Walgreens Healthcare Clinics Able to Prescribe PrEP for HIV Prevention in 17 Additional Markets
July 10th 2017Walgreens today announced that beginning July 13, providers at Walgreens Healthcare Clinic locations in 17 new markets will be able to prescribe PrEP, a medication protocol for people who don’t have HIV to help proactively protect against HIV infection.
Read More
Sugar Consumption During Pregnancy May Cause Allergies and Allergic Asthma in Children
July 7th 2017Researchers at the University of Bristol in the United Kingdom have published a study in European Respiratory Journal that analyzed sugar intake during pregnancy and the relationship to allergies and asthma in children.
Read More
FDA Approves Drug for Active Psoriatic Arthritis
July 6th 2017The FDA has approved Bristol-Myers Squibb’s abatacept (Orencia) in both intravenous (IV) and subcutaneous (SC) injections forms for the treatment of active Psoriatic Arthritis (PsA) in adults. The approval is the third autoimmune disease indication for Orencia.
Read More
FDA Orders Drug Compounding Company to Halt Operations
July 6th 2017FDA officials said that U.S. District Judge William H. Steele has entered a consent decree of permanent injunction against compounder Medistat RX, LLC, prohibiting the company from manufacturing or distributing products until it complies with appropriate regulations.
Read More